3
dimer 11 were also present, but no adducts were observed from
the bond cleavage leading to the benzylic cation.
3. Conclusion
We have successfully carried out a unique investigation
comparing an aromatic ring and an allyl group as donors in the
donor-acceptor cyclobutane [4+2]-cycloaddition reaction. The
crucial fact that cyclobutane ring cleavage exclusively led to the
allylic cation with no sign of the alternate bond cleavage
demonstrated, at least for this system, allylic stablisation is
superior to benzylic stablisation for this [4+2]-cycloaddition. We
have shown that when the donor-acceptor cyclobutane has a
choice of cleavage between a benzylic bond and an allylic bond,
only the allylic bond is broken under Lewis acid conditions. We
are currently looking at making use of this knowledge in
expanding the reaction and the synthesis of highly substituted
tetrahydropyrans.
References
1. S. D. R. Christie, R. J. Davoile, M. R. J. Elsegood, R. Fryatt, R. C.
F. Jones and G. J. Pritchard, Chem. Commun., 2004, 2474; S. D.
R. Christie, R. J. Davoile and R. C. F. Jones, Org. Bio. Chem.,
2006, 4, 2683; S. D. R. Christie, J. Cummins, M. R. J. Elsegood
and G. Dawson, Synlett, 2009, 257.
2. E. A. Ellart, M. R. J. Elsegood, S. D. R. Christie and G. J.
Pritchard, Chem. Commun., 2009, 7339.
3. W. R. Bowman, J. E. Lyon and G. J. Pritchard, Synlett, 2008,
2169; W. R. Bowman, J. E. Lyon and G. J. Pritchard, ARKIVOC,
2012, part vii, 210. S. D. R. Christie, A. D. Warrington, C. J.
Lunniss, Synthesis, 2009, 148. R. J. Davoile, D. T. Rutherford, S.
D. R. Christie, Tetrahedron Lett., 2000, 41, 1255.
4. For example see:- N. R. Irlapati, J. E. Baldwin, R. M. Adlington,
G. J. Pritchard and A. R. Cowley, Tetrahedron, 2006, 62, 4603; R.
M. Adlington, J. E. Baldwin, A. V. W. Mayweg and G. J.
Pritchard, Org. Lett., 2002, 4, 3009; R. M. Adlington, J. E.
Baldwin, G. J. Pritchard, A. J. Williams and D. J. Watkin, Org.
Lett., 1999, 1, 1937; N. R. Irlapati, J. E. Baldwin, R. M. Adlington
and G. J. Pritchard, Org. Lett., 2003, 5, 2351; J. E. Baldwin, R. M.
Adlington, A. Conte, N. R. Irlapati, R. Marquez and G. J.
Pritchard, Org. Lett., 2002, 4, 2125.
5. For examples see:- M. F. A. Adamo, R. M. Adlington, J. E.
Baldwin, G. J. Pritchard and R. E. Rathmell, Tetrahedron, 2003,
59, 2197; J. E. Baldwin, A. M. Fryer and G. J. Pritchard, Bioorg.
Med. Chem. Lett., 2000, 10, 309; R. M. Adlington, J. E. Baldwin,
D. Catterick and G. J. Pritchard, Chem. Commun., 1997, 1757.
6. A. Ahmed, S. D. R. Christie, M. R. J. Elsegood and G. J.
Pritchard, Chem. Commun., 2013, 49, 7489.
7. S. Shimada, K. Saigo, H. Nakamura, M. Hasegawa, Chem. Lett.,
1991, 20, 1149.
8. A. T Parsons and J. S. Johnson, J. Am. Chem. Soc., 2009, 131,
14202.
9. M. M. A. R. Moustafa and B. L. Pagenkopf, Org. Lett., 2010, 12,
4732; M. M. A. R. Moustafa, A. C. Stevens, B. P. Machin and B.
L. Pagenkopf, Org. Lett., 2010, 12, 4736; A. C. Stevens, C.
Palmer and B. L. Pagenkopf, Org. Lett., 2011, 13, 1528; B. P.
Machin and B. L. Pagenkopf, Synlett, 2011, 2799; R. Okado, A.
Nowaki, J. Matsuo, H. Ishibashi, Chem. Pharm. Bull., 2012, 60,
21.
10. J. Matsuo, S. Sasaki, H. Tanaka and H. Ishibashi, J. Am. Chem.
Soc., 2008, 130, 11600; J. Matsuo, S. Sasaki, T. Hoshikawa and
H. Ishibashi, Tetrahedron Lett., 2009, 50, 5831; J. Matsuo, S.
Sasaki, T. hoshikawa and H Ishibashi, Org. Lett., 2009, 11, 3822;
J. Matsuo, S. Negishi, H. Ishibashi, J. Matsuo, R. Okado and H.
Ishibashi, M. Kawano, Org. Lett., 2010, 12, 3266; S. Negishi, H.
Ishibashi and J. Matsuo, Org. Lett., 2010, 12, 4984; T. Kiuchi, J.
Matsuo and H. Ishibashi, Tetrahedron Lett., 2012, 53, 432; M.
Kawano, T. Kiuchi, S. Negishi, H. Tanaka, T. Hoshikawa, J.
Matsuo and H. Ishibashi, Anrew. Chem. Int. Ed., 2013, 52, 906.
11. G. Shan, X. Sun Q. Xia and Y. Rao, Org. Lett., 2011, 13, 5770; Y.
Cheng, X. Han. H Ouyang and Y. Rap, Chem. Commun., 2012,
48, 1757.
12. R. K. Boeckman Jr., M. R. Reeder, J. Org. Chem., 1997, 62, 6456.
13. A. Ma, S Zhu and D. Ma, Tetrahedron Lett., 2008, 49, 3075.